Asymmetry Capital Management as of Sept. 30, 2016
Portfolio Holdings for Asymmetry Capital Management
Asymmetry Capital Management holds 20 positions in its portfolio as reported in the September 2016 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Ptc Therapeutics I (PTCT) | 13.8 | $8.0M | 568k | 14.01 | |
| Aerie Pharmaceuticals | 9.9 | $5.7M | 151k | 37.74 | |
| BIO-RAD LABORATORIES Inc Cl A Com Stk | 8.7 | $5.0M | 31k | 163.82 | |
| Amicus Therapeutics (FOLD) | 8.0 | $4.6M | 618k | 7.40 | |
| Centene Corporation (CNC) | 7.9 | $4.5M | 68k | 66.97 | |
| Impax Laboratories | 6.8 | $3.9M | 164k | 23.70 | |
| UnitedHealth (UNH) | 6.8 | $3.9M | 28k | 140.00 | |
| Incyte Corporation (INCY) | 6.1 | $3.5M | 37k | 94.29 | |
| Jazz Pharmaceuticals (JAZZ) | 6.0 | $3.4M | 28k | 121.47 | |
| Eli Lilly & Co. (LLY) | 4.6 | $2.7M | 33k | 80.26 | |
| Ironwood Pharmaceuticals | 4.1 | $2.4M | 150k | 15.88 | |
| Neurocrine Biosciences (NBIX) | 3.3 | $1.9M | 38k | 50.63 | |
| Synergy Pharmaceuticals | 3.2 | $1.9M | 339k | 5.51 | |
| Edwards Lifesciences (EW) | 2.9 | $1.7M | 14k | 120.58 | |
| Novocure | 2.3 | $1.3M | 157k | 8.54 | |
| Nevro (NVRO) | 2.2 | $1.3M | 12k | 104.35 | |
| Flamel Technologies | 1.2 | $716k | 58k | 12.39 | |
| Galapagos Nv | 0.7 | $404k | 6.3k | 64.64 | |
| Quest Diagnostics | 0.7 | $398k | 4.7k | 84.68 | |
| Glaukos | 0.7 | $386k | 10k | 37.72 |
